Fiasp ultra-fast-acting Penfill
Fiasp ultra-fast-acting Penfill is a medicine authorised by Swissmedic under authorisation number 66201. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 June 2017 and the authorisation is valid without a time limit. ATC code A10AB05 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 66201 |
|---|---|
| Name | Fiasp ultra-fast-acting Penfill |
| Full name | Fiasp ultra-fast-acting Penfill, Injektionslösung |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AB05 |
| First authorisation | 07 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fiasp ultra-fast-acting Penfill, Injektionslösung | B | 07 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 3 | ml | A10AB05 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fiasp ultra-fast-acting Penfill authorised in Switzerland?
Yes. Fiasp ultra-fast-acting Penfill is authorised by Swissmedic under authorisation number 66201, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fiasp ultra-fast-acting Penfill have?
Fiasp ultra-fast-acting Penfill is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Fiasp ultra-fast-acting Penfill?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.